SCHEMBL2435872

SCHEMBL2435872

CN(CCc1ccccc1)c1ncc(C(=O)O)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
PKM P14618 1/20 0.43
TMPRSS15 P98073 4/20 0.42
GLS O94925 1/20 0.42
RPS6KB1 P23443 1/20 0.42
AKT1 P31749 1/20 0.42
AGTR1 P30556 3/20 0.41
AGTR2 P50052 3/20 0.41
HCAR2 Q8TDS4 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
DAO P14920 1/20 0.40
AOC3 Q16853 1/20 0.39
NPC1 O15118 2/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2439181 0.85 CDC7 (0.49) ALDH1A1KDM4ETMPRSS15NPC1MAPT
SCHEMBL31482107 0.76 MLYCD (0.44) ALDH1A1KDM4ETMPRSS15AGTR1AGTR2
SCHEMBL25410152 0.75 TMPRSS15 (0.59) TMPRSS15HCAR2
SCHEMBL17607366 0.75 HCAR2 (0.47) ALDH1A1KDM4ETMPRSS15AGTR1AGTR2
SCHEMBL15530378 0.74 KDM4E (0.48) ALDH1A1KDM4ETMPRSS15AGTR1AGTR2
SCHEMBL25408977 0.74 TMPRSS15 (0.60) ALDH1A1TMPRSS15HCAR2RAB9A
SCHEMBL24853458 0.73 HCAR2 (0.57) ALDH1A1KDM4ETMPRSS15AGTR1AGTR2
SCHEMBL17967192 0.73 DAO (0.50) ALDH1A1KDM4EHCAR2DAONPC1
SCHEMBL7832601 0.71 ALDH1A1 (0.54) ALDH1A1KDM4EHDAC3HDAC4HDAC6
SCHEMBL11566151 0.70 HCAR3 (0.69) PKMRPS6KB1AKT1TAAR1AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945617-B1 HISTONE DEACETYLASE INHIBITORS WITH ARYL-PYRAZOLYL MOTIFS MERCK SHARP & DOHME (US) 2012-12-26 EP disclosed
US-8026260-B2 Histone deacetylase inhibitors with aryl-pyrazolyl-motifs MERCK SHARP & DOHME CORP. (US) 2011-09-27 US disclosed
US-8026260-B2 Histone deacetylase inhibitors with aryl-pyrazolyl-motifs MERCK SHARP & DOHME CORP. (US) 2011-09-27 US disclosed
US-8026260-B2 Histone deacetylase inhibitors with aryl-pyrazolyl-motifs MERCK SHARP & DOHME CORP. (US) 2011-09-27 US disclosed
US-20090291965-A1 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs MERCK SHARP & DOHME LLC 2009-11-26 US disclosed
US-20090291965-A1 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs MERCK SHARP & DOHME LLC 2009-11-26 US disclosed
US-20090291965-A1 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs MERCK SHARP & DOHME LLC 2009-11-26 US disclosed
WO-2007055941-A2 HISTONE DEACETYLASE INHIBITORS WITH ARYL-PYRAZOLYL MOTIFS MERCK & CO., INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291965-A1 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs HDAC1, HDAC3, HDAC5 ALDH1A1 540/4885KDM4E 97/4885PKM 1570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.